The p16INK4a localization in malignant cells is suggested to be correlated to the overall survival and progression-free interval in patients with head and neck cancer, with a cytosolic p16INK4a localization being associated to a less favorable prognosis (Zhao et al. 2012). This evidence concerns the gene CDKN2A and head and neck cancer.